Abortion
Almeida backtracks and denies post-abortion syndrome existence
October 03, 2025 AI 生成的图像
Madrid's mayor, José Luis Martínez-Almeida, has backtracked on his stance, now stating that post-abortion syndrome does not exist as a recognized scientific category. This contrasts with support from Spanish bishops and parties like Vox and PP for the concept, despite clear scientific denial. The debate arises amid political discussions on abortion in Spain.
Federal judge strikes down FDA limits on abortion pill
October 03, 2025 由 AI 报道
A U.S. federal judge in Maryland ruled that the FDA's restrictions on the abortion medication mifepristone were unlawful, benefiting plaintiffs from three states. The decision blocks requirements for in-person dispensing and a reduced gestational age limit. This preserves broader access to the drug used in most medication abortions.
Federal judge blocks Idaho abortion ban in emergencies
A federal judge in Idaho has ruled that the state's strict abortion ban cannot be enforced in medical emergencies, providing temporary relief to healthcare providers. The decision addresses concerns that the law endangers women by creating uncertainty in critical situations. This ruling comes amid ongoing legal challenges to post-Roe v. Wade restrictions.
Federal judge blocks expanded access to abortion pill mifepristone
October 03, 2025 由 AI 报道
A federal judge in Texas has issued a ruling limiting the FDA's approval of mifepristone, the primary drug used in medication abortions. The decision revives a long-standing lawsuit challenging the drug's safety and regulatory process. This comes amid ongoing legal battles over abortion access following the Supreme Court's overturning of Roe v. Wade.
Supreme Court upholds FDA approval of mifepristone
The U.S. Supreme Court unanimously ruled on June 13, 2024, that the FDA's approval of the abortion pill mifepristone is valid and remains in effect. The decision dismissed challenges from anti-abortion groups, affirming the agency's regulatory authority. This ruling ensures continued access to medication abortion, which accounts for more than half of U.S. abortions.